Abstract Background: Medical Cannabis (MC) is authorized in numerous state-legislated programs to treat approved medical conditions. Notwithstanding MC access, some…
Abstract Background: Research utilization is critical in evidence-based practice, enhancing patient outcomes and professionalism of service providers. Despite its importance,…
Abstract Background/Objectives: The COVID-19 pandemic has significantly affected public health and social behavior, contributing to increased psychoactive substance (PAS) use…
Abstract Background: Cannabidiol (CBD) is a cannabinoid present in the hemp plant (Cannabis sativa L.). Non-medicinal CBD oils with typically…
Abstract Background/Objectives: Addictive and substance-related disorders represent a substantial public health challenge, marked by rising incidence and prevalence rates. Men…
Abstract Cannabidiol (CBD), a non-psychotropic main component of the Cannabis plant, has been approved as a drug in the European…
Abstract There is a growing demand for vegan products and plant-based food when dealing with the impact of livestock on…
Abstract Cannabis-based medicines (CBMs) could help reduce systemic inflammation in people with HIV (PWH). In a prospective, randomized pilot study…
Abstract Background: Medication administration errors significantly impact patient safety, potentially leading to severe harm or fatality. Reporting such errors through…
Abstract Background: Medical cannabis use and public acceptance in the United States have increased over the past 25 years. However,…